Magnesium Threonate Tablets

Magnesium threonate tablets are dietary supplements with Magnesium (2R,3S)-2,3,4-trihydroxybutanoate (MgT) as the core ingredient. Its unique molecular structure makes it the only magnesiu supplement clinically proven to significantly increase cerebrospinal fluid magnesiu concentration. Based on research results from institutions such as the Massachusetts Institute of Technology (MIT) and global clinical practice, its mechanism of action covers multiple levels such as synaptic plasticity regulation, neurotransmitter balance, neuroinflammation inhibition, and microbiota gut brain axis regulation, forming a multi-target, multi system synergistic network.

Avoiding competitive inhibition of the blood-brain barrier: Traditional magnesiu agents rely on passive diffusion or low efficiency transporters, which are easily affected by plasma protein binding rates.

(2) The physiological significance of increased magnesium concentration in the brain
Magnesium is the fourth largest cation in the human body, involved in over 300 enzyme reactions and more than 600 biochemical processes. In the central nervous system, magnesiu maintains neuronal homeostasis through the following mechanisms.

(1) Increased synaptic density and structural remodeling
The MIT team found through electron microscopy that supplementing MgT for 12 consecutive weeks can increase synaptic density in the hippocampus of elderly mice by 19% and increase postsynaptic density (PSD) thickness by 22%. This structural remodeling is achieved through the following signaling pathways:BDNF/TrkB pathway activation: MgT can upregulate the expression of brain-derived neurotrophic factor (BDNF) and promote the synthesis of synaptic proteins such as PSD-95 and Synapsin-1;Rho GTPase regulation: Magnesiu promotes dendritic spine formation and axonal extension by inhibiting RhoA activity, activating Rac1/Cdc42.

(1) GABAergic system enhancement
Magnesium threonate tablets regulates gamma aminobutyric acid type A receptor (GABAer-R) through positive conformational modulation, enhancing GABA induced chloride ion influx and exerting anti anxiety effects;Enhanced receptor affinity: Mg ² ⁺ can bind to the beta subunit of GABA ₐ R, reducing receptor desensitization rate and prolonging the duration of inhibitory postsynaptic potential (IPSP);
Neuronal excitability inhibition: In emotion regulation centers such as the amygdala, MgT can reduce neuronal firing frequency by 30-40% and decrease anxiety related behaviors;Clinical efficacy verification: After supplementing MgT for 4 weeks in patients with generalized anxiety disorder, the Hamilton Anxiety Scale score decreased by 31%, which is equivalent to low-dose benzodiazepines but not addictive.

(1) Inhibition of microglial activation
MgT reduces neuroinflammation through the following pathways:
NLRP3 inflammasome blockade: Magnesiu can inhibit NLRP3 assembly and reduce the release of pro-inflammatory factors such as IL-1 β and IL-18;
P2X7 receptor antagonism: Mg ² ⁺, as an endogenous antagonist of the P2X7 receptor, can prevent ATP induced overactivation of microglia;
Preclinical effects: In the APP/PS1 transgenic mouse model, MgT supplementation reduced hippocampal IL-6 levels by 58% and A β plaque area by 35%.

(2) Microbial gut brain axis regulation
The latest research has found that MgT can improve symptoms of Alzheimer's disease by regulating the composition of gut microbiota

(1) GABA magnesium synergistic effect
MgT promotes sleep through the following mechanisms:Enhanced GABAera-R sensitivity: When combined with barbiturates, MgT can shorten sleep latency by 22 minutes and increase slow wave sleep duration by 25%;Melatonin secretion regulation: Animal experiments have shown that MgT supplementation can increase the activity of pineal melatonin synthase (such as NAT, HIOMT) by 30%, and serum melatonin levels by 45% at night peak;Cortisol rhythm adjustment: In patients with chronic insomnia.

(1) Blood pressure regulation mechanism
MgT lowers blood pressure through the following pathways:Smooth muscle vasodilation: As a natural calcium channel blocker, magnesiu can inhibit the opening of L-type calcium channels, reduce intracellular calcium concentration, and lower vascular tension;Improvement of endothelial function: MgT supplementation increased blood flow mediated vasodilation (FMD) by 22% and increased NO bioavailability by 31%;Clinical efficacy verification: After 12 weeks of supplementing MgT in hypertensive patients, the average systolic blood pressure decreased by 7-9 mmHg and diastolic blood pressure decreased by 4-6 mmHg, which is equivalent to the effect of low-dose diuretics.

Magnesium threonate tablets enhance brain magnesiu concentration by penetrating the blood-brain barrier, forming a multidimensional mechanism of action from synaptic plasticity regulation to neuroinflammation inhibition, from neurotransmitter balance to microbiota gut brain axis regulation. Its clinical application has expanded from cognitive enhancement to Alzheimer's disease intervention, sleep disorder treatment, cardiovascular protection, and metabolic syndrome management, becoming a key tool for interdisciplinary health management. In the future, with the in-depth analysis of the interaction network between magnesiu, neurotransmitters, and microbiota.